Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07141537 · ClinicalTrials.gov registry record
Caloric Balance Markers Study
A clinical trial of Metabolism, sponsored by Institute for Systems Biology.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT07141537: Recruiting study of Metabolism, sponsored by Institute for Systems Biology.
NCT07141537 is a study of Metabolism that is actively recruiting participants, run by Institute for Systems Biology. The registered enrollment target is 400 participants, below the 13,245-participant average among 19 other Metabolism trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07141537, a study of Metabolism, is actively recruiting participants, sponsored by Institute for Systems Biology.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of CaBooM is to identify and characterize biomarkers of caloric balance-the relationship between energy intake (calories consumed) and energy expenditure (calories burned).
Primary Outcome
calories
Conditions Studied
Study Locations (1)
Washington
- Institute for Systems Biology - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-08-27 |
| Est. Completion | 2033-08-31 |
What NCT07141537 shows while recruiting
NCT07141537 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 13,245-participant average among 19 other Metabolism trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Metabolism appearing as the primary indexed condition, and to 0 interventions.
NCT07141537 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT07141537 about?
NCT07141537 is a clinical study titled "Caloric Balance Markers Study". The purpose of CaBooM is to identify and characterize biomarkers of caloric balance-the relationship between energy intake (calories consumed) and energy expenditure (calories burned).
What is the current status of trial NCT07141537?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2025-08-27. Estimated completion is 2033-08-31.
What conditions does trial NCT07141537 study?
This clinical trial studies the following conditions: Metabolism.
Who is sponsoring clinical trial NCT07141537?
This trial is sponsored by Institute for Systems Biology, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07141537 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07141537's enrollment target sits among peer trials
400 3rd of 19 higher than 17 of 19 other Metabolism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women
RECRUITING · NA
-
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
RECRUITING · Phase 2
-
Studying Phenotypic Risks for Obesity and Underlying Traits in Young Infants
RECRUITING
-
Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells
RECRUITING · NA
-
Personalized Responses to Dietary Composition Trial 3
RECRUITING · NA
-
Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI